Skip to main content

Table 4 Multivariable logistic regressions (associations between therapy received and cohort/other covariates)

From: Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points

  Adjusted odds ratio (95% CI) of therapy received
Therapy received Polytherapy High dose Polytherapy and high dose
Model size n = 400 n = 400 n = 312
Cohort (base: 1st) 1.81 (1.08–3.02)* - 2.14 (1.10–4.17)*
Gender (base: male) - - -
Age (year) - - -
Ethnicity (base: Australian) - - -
Adm. in last 12 m (base: one or two):    
- three or four 1.77 (0.87–3.60) - 2.28 (0.97–5.35)
- five or more 7.52 (2.92–19.4)* - 5.30 (1.57–17.8)*
Hospital stay (day) ^ ^ ^
Primary diagn. (base: schizophrenia):    
- bipolar disorder 0.19 (0.08–0.47)* - 0.26 (0.08–0.80)*
- other psychotic disorder 0.33 (0.14–0.75)* - 0.33 (0.11–1.00)
- other 0.40 (0.21–0.76)* - 0.40 (0.17–0.91)*
Comorbid substance use disorder - - -
Involuntary treatment 3.95 (2.31–6.77)* 2.22 (1.34–3.66)* 3.18 (1.61–6.29)*
Previous clozapine trial 5.80 (2.43–13.8)* 2.19 (1.10–4.38)* 5.58 (2.04–15.3)*
  1. CI confidence interval, * p < 0.05; hyphen = excluded from multivariable model at p ≥ 0.50; ^ = excluded due to multicorreality; m months, diagn. diagnosis, adm. admissions